ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
EHA® 2023
ecancer
2023 EHA® Insights: "ADCLEC.syn1, a Novel Dual-Targeting CAR-T in Humanized AML Models"
FEATURING
Sascha Haubner
- 11 views
- July 5, 2023
ecancer
2023 EHA® Insights: "Addition of Blinatumomab to Mini-HyperCVD & Inotuzumab in R/R B-ALL"
FEATURING
Nicholas Short
- 39 views
- July 5, 2023
ecancer
2023 EHA® Insights: "Belantamab Mafodotin Monotherapy in R/R Light Chain Amyloidosis"
FEATURING
Efstathios Kastritis
- 58 views
- July 5, 2023
ecancer
2023 EHA® Insights: "DREAMM-3 Update on Belantamab Mafodotin vs. Pomalidomide + Dexamethasone in R/R MM"
FEATURING
Meletios Dimopoulos
- 146 views
- July 5, 2023
ecancer
2023 EHA® Insights: "KarMMa-3 Analysis of Ide-Cel vs. Standard Regimens in High-Risk R/R MM"
FEATURING
Krina Patel
- 162 views
- July 5, 2023
ecancer
2023 EHA® Insights: "CIBMTR Real-World Outcomes of Brexu-Cel in Patients With R/R MCL"
FEATURING
Nausheen Ahmed
- 16 views
- July 5, 2023
ecancer
2023 EHA® Insights: "Final Results From the CARTITUDE-1 Study of Cilta-Cel in Heavily Pretreated R/R MM"
FEATURING
Nikhil Munshi
- 74 views
- July 5, 2023
